RESUMO
The Primary Care physician must know the risk factors and to suspect the presence of a pulmonary thromboembolism (PTE) when there is a compatible clinical picture. We present two cases of a massive PTE in young healthy women in whom the taking of ethinylestradiol combined with cyproterone acetate was the only existing risk factor. We believe that the recommendations of the Spanish Medicines Agency should be followed and prescribe those contraceptives that have less than 30ug of ethinylestradiol and a second generation gestagen.
Assuntos
Anticoncepcionais Orais Combinados/efeitos adversos , Acetato de Ciproterona/efeitos adversos , Estrogênios/efeitos adversos , Etinilestradiol/efeitos adversos , Embolia Pulmonar/induzido quimicamente , Adulto , Feminino , Humanos , Atenção Primária à Saúde , Adulto JovemRESUMO
El médico de atención primaria debe conocer los factores de riesgo y sospechar la presencia de una tromboembolismo pulmonar (TEP) ante un cuadro clínico compatible. Presentamos 2 casos de TEP masivos en mujeres jóvenes sanas en las que la toma de etilnilestradiol asociado a acetato de ciproterona era el único factor de riesgo existente. Creemos necesario atender a las recomendaciones de la Agencia Española del Medicamento y prescribir aquellos anticonceptivos que aporten menos de 30 μg de etinilestradiol y un gestágeno de segunda generación (AU)
The Primary Care physician must know the risk factors and to suspect the presence of a pulmonary thromboembolism (PTE) when there is a compatible clinical picture. We present two cases of a massive PTE in young healthy women in whom the taking of ethinylestradiol combined with cyproterone acetate was the only existing risk factor. We believe that the recommendations of the Spanish Medicines Agency should be followed and prescribe those contraceptives that have less than 30ug of ethinylestradiol and a second generation gestagen (AU)
